...
首页> 外文期刊>Clinical & developmental immunology. >Corrigendum to “Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV”
【24h】

Corrigendum to “Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV”

机译:“两个人乳头瘤病毒疫苗真的相似吗?”的勘误对现有证据的系统评价:两种疫苗对HPV的效力”

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In the article titled Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV [1], there was an error in the Discussion section, where Our systematic review highlights that, for precancerous lesions (CIN), the only available proxy of cervical cancer and heterogeneity among pooled studies is substantial should be changed to Our systematic review highlights that, for precancerous lesions (CIN), the only available proxy of cervical cancer, heterogeneity among pooled studies is substantial. In addition, there was an error in Table 3. The corrected table is as follows.Baseline characteristics of women enrolled in the four studies presented in the meta-analysis.
机译:在标题为“两种人乳头瘤病毒疫苗真的相似”的文章中吗?现有证据的系统评价:两种疫苗对HPV的有效性[1],“讨论”部分存在错误,我们的系统评价着重指出,对于癌前病变(CIN),宫颈癌和异质性是唯一可用的代理合并研究中的实质性内容应改为。我们的系统综述强调,对于癌前病变(CIN),宫颈癌的唯一可用替代方法,合并研究中的异质性非常重要。此外,表3中存在错误。更正后的表如下。荟萃分析中四项研究的女性基线特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号